VN
Venkata Nagalakshmi Akula
About Venkata Nagalakshmi Akula
Data last updated:
Venkata Nagalakshmi Akula is a Director at Russet Therapeutics Private Limited (since 2024). The company operates in Trading. Russet Therapeutics Private Limited reported revenue of ₹77.9 Lakh (FY 2023).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Russet Therapeutics Private Limited U51909AP2021PTC119335 | Director | 28 Feb 2024 | 2021 | ₹77.9 Lakh (FY 2023) | Active |
Board colleagues of Venkata Nagalakshmi Akula
| Name | DIN | Company | Designation |
|---|---|---|---|
| Sri Ravi Chandra Naga Radha Gopal Soorabathula | 09306626 | Russet Therapeutics Private Limited | Managing Director |
| Venkata Nageswara Rao Thoram | 09306625 | Russet Therapeutics Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Venkata Nagalakshmi Akula
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Venkata Nagalakshmi Akula
Venkata Nagalakshmi Akula currently holds 1 directorship: Russet Therapeutics Private Limited (Director, since 28 Feb 2024, revenue ₹77.9 Lakh (FY 2023)).
Venkata Nagalakshmi Akula was first appointed on 28 Feb 2024 as Director at Russet Therapeutics Private Limited.
The current boards of Venkata Nagalakshmi Akula's companies include Sri Ravi Chandra Naga Radha Gopal Soorabathula (Russet Therapeutics Private Limited), Venkata Nageswara Rao Thoram (Russet Therapeutics Private Limited).